BCIQ Profiles

Company Profile Report

May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven

Abstracts were released late Wednesday ahead of the American Society of Clinical Oncology meeting starting May 31 in Chicago. See below for BioCentury's first round of Quick Takes on selected abstracts.

Iovance gains on 44% ORR for LN-145 in cervical cancer
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) jumped $2.10 (19%) to $13.33 in

Read the full 509 word article

How to gain access

Continue reading with a
two-week free trial.